Previous close | 287.37 |
Open | 288.27 |
Bid | 286.49 x 100 |
Ask | 286.91 x 100 |
Day's range | 285.61 - 291.80 |
52-week range | 176.34 - 413.20 |
Volume | |
Avg. volume | 619,121 |
Market cap | 21.57B |
Beta (5Y monthly) | 1.64 |
PE ratio (TTM) | 47.28 |
EPS (TTM) | 6.06 |
Earnings date | 24 Jul 2024 - 29 Jul 2024 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 338.96 |
Strong demand for Integra's (IART) diverse portfolio of leading brands and continued successful market adoption of CereLink contributes to its revenues.
Quest Diagnostics' (DGX) pathology laboratories nationwide are set to get a boost with PathAI's AISight digital pathology image management system.
Here is how Align Technology (ALGN) and Aadi Bioscience, Inc. (AADI) have performed compared to their sector so far this year.